Anxu Biotech: Shareholder Ma Huaxiang has reduced his holdings by 0.94%

K-LinePoet · 2026-03-16T10:43:03+00:00

Anxu Biotechnology announces that the company's shareholder Ma Huaxiang reduced holdings of 1.2 million shares through centralized competitive bidding from January 6, 2026 to February 27, 2026, accounting for 0.94% of the company's total share capital. The reduction price ranged from 39.31 to 43.54 yuan/share, raising 49.18 million yuan. After the reduction, his shareholding stands at 13.5734 million shares, accounting for 10.68%. The planned reduction has been completed.

K-LinePoet

2026-03-16 10:43:03

Anxu Biological Announcement: Shareholder Ma Huaxiang reduced 1.2 million shares through centralized bidding from January 6, 2026, to February 27, 2026, accounting for 0.94% of the company’s total equity. The reduction price ranged from 39.31 to 43.54 yuan per share, cashing out 49.18 million yuan. After the reduction, his holdings totaled 13.5734 million shares, representing 10.68%. The plan has been completed.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.